cyppa (Alomone Labs)


Structured Review

Cyppa, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cyppa/product/Alomone Labs
Average 93 stars, based on 4 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Orai1 Boosts SK3 Channel Activation"
Article Title: Orai1 Boosts SK3 Channel Activation
Journal: Cancers
doi: 10.3390/cancers13246357

Figure Legend Snippet: SK3–Orai1 interplay in LNCaP cells: Inset table and chemical structures represent the used agonist and antagonist of SK and Orai1 channels. ( A ) Cell viability of LNCaP cells after 24, 48, 72, and 96 h upon the treatment with SK3 channel agonist 10 μM Cyppa, 5 μM NS309, and antagonist 30 μM NS8593, 10 mM 4-AP detected via MTS assay; ( B ) Block diagram represents the cell proliferation of LNCaP cells after 96 h upon conditions described in ( A ). The Mann–Whitney test was used for statistical comparison considering differences statistically significant at p
Techniques Used: MTS Assay, Blocking Assay, MANN-WHITNEY
2) Product Images from "Ethanol’s Effects on Transient Receptor Potential Channel Expression in Brain Microvascular Endothelial Cells"
Article Title: Ethanol’s Effects on Transient Receptor Potential Channel Expression in Brain Microvascular Endothelial Cells
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
doi: 10.1007/s11481-018-9796-3

Figure Legend Snippet: Endothelial cell barrier permeability following treatment with a) different concentrations of EtOH or b) the TRPM7 antagonists, NS8593, CyPPA, or SKA-31. * p
Techniques Used: Permeability
3) Product Images from "Ethanol’s Effects on Transient Receptor Potential Channel Expression in Brain Microvascular Endothelial Cells"
Article Title: Ethanol’s Effects on Transient Receptor Potential Channel Expression in Brain Microvascular Endothelial Cells
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
doi: 10.1007/s11481-018-9796-3

Figure Legend Snippet: Endothelial cell barrier permeability following treatment with a) different concentrations of EtOH or b) the TRPM7 antagonists, NS8593, CyPPA, or SKA-31. * p
Techniques Used: Permeability